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Abstract
The mitotic checkpoint complex (MCC) ensures the Wdelity of chromosomal segregation, by delaying the onset of anaphase until
all sister chromatids have been properly attached to the mitotic spindle. In essence, this MCC-induced delay is achieved via the inhi-
bition of the anaphase-promoting complex (APC). Among the components of the MCC, BubR1 plays two major roles in the func-
tions of the mitotic checkpoint. First, BubR1 is able to inhibit APC activity, either by itself or as a component of the MCC, by
sequestering a APC coactivator, known as Cdc20. Second, BubR1 activates mitotic checkpoint signaling cascades by binding to the
centromere-associated protein E, a microtubule motor protein. Obtaining highly soluble BubR1 is a prerequisite for the study of its
structure. BubR1 is a multi-domain protein, which includes a KEN box motif, a mad3-like region, a Bub3 binding domain, and a
kinase domain. We obtained a soluble BubR1 construct using a three-step expression strategy. First, we obtained two constructs
from BLAST sequence homology searches, both of which were expressed abundantly in the inclusion bodies. We then adjusted the
lengths of the two constructs by secondary structure prediction, thereby generating partially soluble constructs. Third, we optimized
the solubility of the two constructs by either chopping or adding a few residues at the C-terminus. Finally, we obtained a highly solu-
ble BubR1 construct via the Escherichia coli expression system, which allowed for a yield of 10.8 mg/L culture. This report may pro-
vide insight into the design of highly soluble constructs of insoluble multi-domain proteins.
  2005 Elsevier Inc. All rights reserved.
Keywords: BubR1; Structure; Anaphase-promoting complexIn the eukaryotic cell cycle, mitosis consists of six
sequential phases: prophase, prometaphase, metaphase,
anaphase, telophase, and cytokinesis. During metaphase,
two sister chromatids align in the equatorial plane of the
dividing cell, while mitotic spindles attach themselves to
the kinetochores in the centromeres of the sister chro-
matids. The mitotic spindle-attached sister chromatids
are then separated, and pulled into each spindle pole,
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doi:10.1016/j.pep.2005.04.020thereby completing chromosomal duplication. The
mitotic checkpoint (also called the spindle assembly
checkpoint) ensures the Wdelity of this chromosomal seg-
regation, by delaying the onset of anaphase until all sis-
ter chromatids have been properly attached to the
mitotic spindle [1].
Mad1 [2], Mad2 [3,4], Bub1 [4], Bub3 [5], and BubR1
[6,7] are some characteristic mitotic checkpoint proteins.
These proteins associate with the unattached kineto-
chores and are involved in the delay in the metaphase/
anaphase transition [4,5,7–9]. In essence, this delay
occurs due to inhibition of the anaphase-promoting
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which targets key proteins for destruction, a step neces-
sary for the separation of the sister chromatids [10–13].
The mitotic checkpoint complex (MCC), which
includes the BubR1, Bub3, Cdc20, and Mad2 proteins, in
nearly equal stoichiometry, has been shown to eVect the
inhibition of APC activity [14]. The eVects of individual
checkpoint proteins have also been reported. For exam-
ple, BubR1 alone has been shown to inhibit APC activ-
ity in a much more profound manner than does Mad2
[15]. Two distinct models for the mechanism underlying
MCC-induced APC inhibition have been proposed. In
the Wrst model, the unattached kinetochore functions as
a template which catalyzes the formation of the BubR1–
Bub3–Mad2–Cdc20 (MCC) complex, which then
diVuses away from the kinetochore, to inhibit APC. In
the second model, the modiWcation (primarily phosphor-
ylation) of APC by the unattached kinetochore pro-
motes its association with the MCC, thereby resulting in
APC inhibition [16].
Among these MCC proteins, BubR1 has been identi-
Wed as a Mad3/Bub1-related protein kinase, predicated on
its homology with the N-terminal domain of budding
yeast Mad3, which interacts with Cdc20 [5]. The C-termi-
nal kinase domain of BubR1 is reliant on centromere-
associated protein E (CENP-E)-dependent activation [17].
BubR1 also phosphorylates Cdc20 in vitro, and the phos-
phorylated Cdc20 consequently precludes its binding to
APC, which thereby inhibits mitotic progression [18].
Therefore, BubR1 plays a principal role in monitoring
the link between microtubule attachment/tension at the
kinetochore, and the movement of the chromosomes
[2,19–21]. BubR1 in the mitotic checkpoint plays two
principal roles. First, BubR1 can inhibit the activity of
APC, either by itself or as a component of the MCC, by
sequestering Cdc20 from the APC [15,16]. Second, BubR1
activates mitotic checkpoint signaling cascades, by bind-
ing to the microtubule motor protein, CENP-E [2,19–21].
The three-dimensional structures of the checkpoint
proteins, Mad1, Mad2 [22,23], and Saccharomyces cere-
visiae Bub3p [24], have been reported in previous works.
The structures of BubR1 and its homolog-proteins, how-
ever, have not yet been reported. The Wrst step in the
structural study of BubR1 was to obtain a large amount
of soluble protein. However, this proved to be the Wrst
bottleneck in the structural study. We attempted to
express BubR1 with the Escherichia coli expression sys-
tem, but it was not easily expressed in soluble form, as
BubR1 is a multi-domain protein, which includes struc-
tures such as a KEN box motif, a mad3-like region, a
Bub3 binding domain, and a kinase domain. Therefore,
2 Abbreviations used: APC, anaphase-promoting complex; MCC, mi-
totic checkpoint complex; CENP-E, centromere-associated protein E;
ME, -mercaptoethanol; CD, circular dichroism; CDD search, con-
served domain database searches.we attempted to design soluble BubR1 constructs, using
homology searches, secondary structure prediction, and
C-terminal residue adjustments. Finally, we did succeed
in the generation of soluble BubR1 constructs, using the
E. coli expression system. This report may, then, provide
insight into the design of highly soluble constructs of
insoluble multi-domain proteins.
Materials and methods
Cloning of BubR1 constructs
BubR1 constructs, which had been designed via
homology searches and secondary structure prediction,
were ampliWed from the full-length BubR1 gene by PCR.
All constructs contained the N-terminal BamHI restric-
tion site, as well as the C-terminal SalI restriction site.
The ampliWed BubR1 constructs were then digested by
BamHI and SalI restriction enzymes, and ligated into the
pET28a(+) vector (Novagen, USA), which resulted in the
cloned BubR1 constructs with both N- and C-terminal
His-tags. The ligated plasmids were then electroporated
into E. coli DH5. The cloned BubR1 constructs were
veriWed by double-restriction digestion, and selected
clones were Wnally conWrmed via DNA sequencing.
Expression and puriWcation of BubR1 constructs
Cloned BubR1 constructs were subsequently trans-
formed into E. coli BL21(DE3) Codonplus-RIL (Strat-
agen, USA) for protein over-expression. This substrate
was selected to solve the codon bias problem [25]. Over-
night culture seeds of BubR1 constructs (5 ml) were then
inoculated into 200 ml of LB medium containing kana-
mycin (50 g/ml), and allowed to grow at 37 °C. When
the optical density of cells at 600 nm reached between 0.5
and 0.6, the production of BubR1 proteins was induced
via the addition of 0.5 mM IPTG at 21 °C. After over-
night induction, the cells were harvested by 10 min of
centrifugation at 4000g. The cell pellets were then resus-
pended in 20 mM Tris–HCl (pH 7.8) containing 200 mM
NaCl, 1 mM -mercaptoethanol (ME), and protease
inhibitor cocktail (Roche, Switzerland). The resus-
pended cells were homogenized by ultra-sonication and
supernatants were separated by 25 min of centrifugation
at 15,000g. The expression proWles of the BubR1 con-
structs were visualized by SDS–PAGE.
To purify the BubR1, the cell lysate supernatants
were loaded onto Ni–NTA resin (Qiagen, USA). Elution
was then performed with 50–500 mM concentration gra-
dient of imidazole. The puriWed BubR1 was identiWed by
SDS–PAGE and then dialyzed against 20 mM sodium
phosphate (pH 7.5), containing 1 mM ME.
All BubR1 constructs (1-310, 1-312, 1-314, 1-316,
1-318, 1-320, 1-322, 1-324, 1-326, 1-328, and 1-330, in
J. Yoon et al. / Protein Expression and PuriWcation 44 (2005) 1–9 3which the two residue numbers linked by a hyphen rep-
resent cloned constructs throughout the text) were puri-
Wed to determine the soluble fraction yield with 200 ml
cultures, but selected BubR1 constructs (1-286 and 1-320)
were then employed for large-scale protein puriWcation
with 4.2 L cultures.
Homology search and secondary structure prediction
The selection of constructs for the cloning of BubR1
was based on comparative amino acid sequence analy-
ses, secondary structure prediction, and functional stud-
ies of BubR1. Comparative sequence analysis was
performed using BLAST [26], and secondary structure
prediction involved the GOR4 consensus program,
including the GOR4 [27], HNN [28], PHD [29], Preda-
tors [30], and SIMPA96 [31] prediction programs. The
GOR4 consensus program reduced prediction errors
and provided reliable predictions with regard to second-
ary structure.
Circular dichroism spectrometry
Far-UV (190–260 nm) circular dichroism (CD) spec-
tra were measured with a Jasco J-715 spectrometer [32].
The CD experiment was performed at 0.5 nm intervals,
in a 0.1 cm quartz cuvette, at 20 °C. The spectra of the
BubR1 constructs 1-286 and 1-320 are expressed as an
average of three scans, to compensate for measurement
errors and buVer absorbance. The protein concentration
was 0.25 mg/ml, buVered by 5 mM sodium phosphate
(pH 7.4). Spectra were digitized by recording in millide-
gree increments, and these values were then converted to
per residue molar absorption, expressed in mdeg/M/cm.
Experimental CD spectra were Wtted to estimate the
composition of the secondary structures, using the COT-
INLL program, at the DICHROWEB website [31,33].
MALDI-TOF and MALDI-TOF/TOF analysis
Smaller bands than expected for the target construct
(residues 1-320) appeared during BubR1 puriWcation.
Thus, we cut out the smaller minor bands with SDS–
PAGE, to ascertain whether or not they represented pro-
teolytically digested forms from the correctly-sized target
protein. Interesting SDS–PAGE spots were excised from
the stained gels, and the gel spots were sequentially
destained, reduced, alkylated, and hydrolyzed, using mod-
iWed porcine trypsin (Promega, Southhampton, UK), as
previously described [34,35]. The extracted in-gel digested
peptides were then identiWed via peptide mass Wngerprint-
ing using MALDI-TOF MS, and the identiWed peptides
were subsequently sequenced via MALDI-TOF/TOF tan-
dem mass spectrometry (MS/MS) (Applied Biosystems,
USA) at the Seoul National University College of Medi-
cine, in Seoul, Korea [36]. Database searches were carriedout using the search program, MASCOT, developed by
Matrix Science Ltd (access is available on http://
www.matrix.science.com), and the ExPASy Molecular
Biology Server at SWISS-PROT (http://www.expasy.ch).
Results and discussion
Preliminary expression of BubR1 domains
Human BubR1 is a multi-domain protein consisting
of 1050 residues [5]. The domains of human BubR1 were
easily identiWed with alignment to Xenopus BubR1,
which is a homolog of human BubR1 [17], using BLAST
software [26]. It turned out that human BubR1 consists
of a KEN box motif (residues 26-28), a mad3-like region
(residues 52-204), a Bub3 binding domain (residues 392-
433), and a kinase domain (749-1018).
Human BubR1 as a multi-domain protein cannot be
easily expressed with the standard E. coli expression sys-
tem. Thus, we examined several distinctive BubR1
domain by sequence homology and conserved domain
database searches (CDD search) using BLAST software
[26]. Protein expression was pre-examined for the
selected BubR1 domains garnered in the BLAST search,
namely, the residues 1-207 (KEN box motif and mad3-
like region), 50-207 (mad3-like region only), 1-460 (KEN
box motif, mad3-like region, and Bub3-binding domain),
50-460 (mad3-like region and Bub3-binding domain),
and 755-1023 (C-terminal kinase domain). The expres-
sion patterns of these domains are shown in Fig. 1. The
constructs without N-terminal regions (residues 50-207
and 50-460) were expressed in inclusion bodies, similarly
to those with N-termini (residues 1-207 and 1-460).
Kinase domains (residues 755-1023) could not be
expressed, even in the inclusion bodies.
Rational design of soluble BubR1 constructs
After expressing the selected domains obtained in the
BLAST search, we assessed the solubility of the BubR1
constructs designed by secondary structure prediction.
The BubR1 constructs, 1-221, 1-238, 1-260, 1-275, 1-286,
1-320, 1-486, 50-221, 50-238, 50-260, 50-275, 50-286, and
50-320, were designed via secondary structure predic-
tion, based on the preliminary expression data obtained
in the previous section, in which the constructs, 1-207,
50-207, 1-460, and 40-460, resulted in inclusion body
expression (Fig. 2). The Wnal amino acids in the con-
structs were chosen such that the residues (221, 241, 260,
275, 286, and 320) were positioned in the random coil
regions of the predicted secondary structures (Fig. 2).
These constructs commonly contain the region (208-381)
which exists between the Mad3-like region (50-207), and
the Bub3-binding region (382-456), with the exception of
construct 1-486.
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eration for all construct designs in this section. All con-
structs were ligated in the random coil regions suggested
in secondary structure prediction (Fig. 2), with one
exception. The construct 1-286 was cut one residue
ahead of the beginning of the -helix, as Leu 287 utilizes
one of the deWcient amino-acyl t-RNA synthetases in the
E. coli system. Among the Wve programs utilized, only
the HNN program predicted that the residue 486 would
be located in the -helix, whereas the other four pro-
grams predicted that the residue 486 would be located in
Fig. 1. Preliminary expression of BubR1 domains. Expression patterns
represent (A) BubR1 construct 1-207, (B) BubR1 construct 50-207, (C)
BubR1 construct 1-460, (D) BubR1 construct 50-460, and (E) BubR1
construct 755-1023 (kinase domain). The arrows represent target pro-
teins throughout the Wgure legends. M, 1, 2, and 3, located at the bot-
tom of the gel, represent molecular weight markers, uninduced cell
lysates, induced cell lysates, and induced supernatants, respectively.
KD represents the kinase domain. The numbers on the vertical column
of (A) represent the molecular weight of the molecular weight marker.
This marker was also used for all the other SDS–PAGE gels.the random coil region. Q487 is located in the random
coil but is a bulky residue. Thus, residue 486 was selected
for the C-terminus of construct 1-486.
Those 13 constructs were evaluated with regard to
their solubility. Some of the constructs (1-221, 1-238,
1-260, 1-275, 1-286, 1-320, and 1-486) were shown, but
soluble expressions were detected only in the 1-286 and
1-320 constructs (Fig. 3). The constructs without the 50
N-terminal residues were all expressed in inclusion
bodies (data not shown). It would appear that the N-ter-
minal region does, indeed, play a primary role in soluble
expression.
By this rational design, using secondary structure pre-
diction programs, we generated two soluble constructs
from the 13 constructs in which the C-termini were posi-
tioned in the random coil region. It turned out that the
previous expression in the inclusion bodies could be
improved to partial solubility by adjusting the C-termi-
nal regions, based on the secondary structure predic-
tions.
PuriWcation of the constructs 1-286 and 1-320
The constructs 1-286 and 1-320, located on the vector
pET28a(+), were expressed in E. coli BL21(DE3)
Codonplus-RIL, and were puriWed via Ni–NTA aYnity
chromatography (Figs. 4A and B). The puriWed 1-286
was found to be unstable at 3 mg/ml during concentra-
tion, whereas the 1-320 construct was determined to be
stable at a concentration of 10 mg/ml. The puriWed 1-320
contained smaller minor contaminated bands, which
were below the target size (Fig. 4B). Therefore, we used
anion ion exchange chromatography with Q-Sepharose,
to eliminate the undesired smaller proteins, as the 1-320
construct had a pI value of 5.4. However, the minor
bands were still found to be co-eluted with the 1-320
construct (Fig. 4C), at an NaCl gradient of 150–300 mM.
We assumed, then, that the smaller contaminated bands
might be degraded forms of the 1-320 construct. We
detected two smaller minor bands to have been co-eluted
with the target construct 1-320 (Fig. 4C), and these
bands were subjected to MALDI-TOF MS for peptide
mass Wngerprinting and, subsequently, to MALDI-TOF/
TOF MS/MS for peptide sequencing (data not shown).
The two smaller minor bands were determined to be pro-
teolytically digested fragments from the target 1-320
construct, the C-termini of which were the residues Arg-
224 and Arg-271. The Arg-224 and Arg-271 residues are
located near the end of the random coil region (Fig. 2).
Presumably, it will be necessary to perform gel Wltra-
tion chromatography to get rid of the smaller minor
contaminant bands of the construct 1-320 in the next
step, to purify only the correctly-sized band for the con-
struct 1-320. Beforehand, it will be crucial to minimize
proteolytic degradation by adding protease inhibitor
cocktail from the cell lysis step during puriWcation.
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To further maximize the solubility of the partially solu-
ble 1-320 construct, we reWned the domain stability by
either chopping or adding a few residues at the C-termi-
nus of the 1-320 construct. The resultant constructs, 1-310,
1-312, 1-314, 1-316, 1-318, 1-322, 1-324, 1-326, 1-328, and
1-330, were designed to further assess the soluble expres-
sion of the new constructs in which the template con-
struct, 1-320, was used as a control. Similar yields of
soluble expression were obtained from constructs 1-310 to1-318, whereas increased yields of soluble expression were
detected when using the 1-322 to 1-328 constructs (Fig. 5).
Quantitation of soluble expression was performed with
the 12 constructs, using the same cell mass (Table 1).
Interestingly, the soluble yield of the 1-330 construct
decreased dramatically (Table 1). It appears that the low
yield of the soluble 1-330 construct might result from the
disruption of the beginning of the -sheet (predicted by
GOR4) or the -helix (predicted by HNN, PHD, Preda-
tor, and SIMPA96) (Fig. 6), in which the C-terminus of
construct 1-330 was terminated in the middle of either theFig. 2. Prediction of secondary structure for the residues 1-500. Secondary structures of residues 1-500 were predicted by the GOR4 consensus pro-
gram, including GOR4 [27], HNN [28], PHD [29], Predators [30], and SIMPA96 [31], which are shown in sequence from top to bottom. The arrows
indicate the N-termini of the BubR1 constructs, the residues of which belong to the notiWed secondary structures seen in the Wgure.
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ruption of the secondary structure at the end region of the
constructs (presumably, also located at the N-terminus)
should be avoided to ensure optimized solubility in the
domain constructs.
The diVerential yield of solubility between con-
structs 1-328 and 1-330 led us to chop out or add a few
residues to the 1-207 construct (Fig. 1), to optimize its
solubility. In contrast to the 1-320 construct, the C-ter-
minal region of the 1-207 construct spans a long -
helix, from residues 149 to 218 (Fig. 2). Thus, we were
not able to rationally choose an appropriate residue forthe C-termini for new constructs, as any C-terminal
residue would be positioned in the middle of the -
helix. Therefore, constructs 1-200, 1-204, and 1-212
were chosen arbitrarily, and used for solubility evalua-
tions. The 1-200 and 1-204 constructs were better
expressed in soluble forms, while construct 1-212 con-
tinued to be expressed in inclusion bodies, identically
to construct 1-207. Surprisingly, the chopping out or
adding of a few residues at the C-terminus resulted in a
minor improvement of the soluble yield of construct 1-
207, although the C-terminus had been chosen in the
middle of the secondary structure, in this case the -Fig. 3. Expression patterns of soluble BubR1 constructs. Figures represent (A) BubR1 construct 1-221, (B) BubR1 construct 1-238, (C) BubR1 con-
struct 1-260, (D) BubR1 construct 1-275, (E) BubR1 construct 1-286, (F) BubR1 construct 1-320, and (G) BubR1 construct 1-486. All constructs
lacking residues 1-50 were expressed in inclusion bodies (data not shown). The gel notations are the same as in Fig. 1.Fig. 4. PuriWcation of the constructs BubR1 1-286 and BubR1 1-320. (A) Ni–NTA aYnity chromatography of the construct BubR1 1-286. (B) Ni–
NTA aYnity chromatography of the construct BubR1 1-320. (C) Q-Sepharose anion exchange chromatography of the construct 1-320. M, S, F, W,
and E1–E5 represent molecular marker, cell supernatant, Xow through, wash fraction, and fraction eluted by imidazole gradient. Smaller minor con-
taminant bands were co-eluted with the BubR1 construct 1-320 in (C). C, M, and salt gradient represent loading fraction, molecular weight marker,
and NaCl gradient eluted fractions.
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QuantiWcation of soluble yields for the BubR1 constructs
Soluble yield is based on 1 L culture. Protein concentrations were





BubR1 1-310 4.4 BubR1 1-320 4.3
BubR1 1-312 4.1 BubR1 1-322 10.4
BubR1 1-314 4.3 BubR1 1-324 8.4
BubR1 1-316 4.3 BubR1 1-326 9.2
BubR1 1-318 4.1 BubR1 1-328 10.8
BubR1 1-320 4.3 BubR1 1-330 1.5
Fig. 6. Secondary structure prediction of the residue 300–350. The
arrow indicates the beginning (residue 329) of a -sheet. There, the C-
terminus of residue 330 disrupted the newly begun -sheet, resulting in
decreasing solubility of the BubR1 construct 1-330. This prediction
was provided by the GOR4 prediction program [27].helix (Fig. 7). However, in contrast to what was
observed withconstruct 1-320, the improvement of the
solubility of construct 1-207 was not as dramatic as
that of construct 1-320, which might be due to the fact
that the C-terminus of construct 1-207 is positioned in
the region of the -helix. Even so, the solubility of
insoluble constructs should be inXuenced radically by a
few residues at the N- or C-terminus. Therefore, the
solubility of the domain construct should be assessed
by the adjustment of a few residues at either the N- or
C-terminus, to determine the maximum yield of protein
expression.
Circular dichroism for BubR1 constructs
CD is useful for the determination of proteins’ sec-
ondary structure, as it allows the researcher to visually
verify the diVerential manner in which a protein absorbs
left- and right-hand circular polarized lights [32]. To
examine the compositions of the secondary structures of
the BubR1 constructs, we obtained the CD spectra of
constructs 1-286 and 1-320. The two CD spectra evi-
denced characteristics typical of -helix-containing pro-Fig. 5. Optimizing solubility of the construct BubR1 1-320. (A) Expression patterns of the BubR1 constructs 1-310, 1-312, 1-314, 1-316, 1-318, 1-320,
1-322, 1-324, 1-326, 1-328, and 1-330. Total yields of each BubR1 construct increased between constructs BubR1 1-320 and 1-328. I and S represent
induced cell lysates and induced cell supernatants, respectively. (B) PuriWcation yields of the BubR1 1-310 to 1-330 constructs (see also Table 1). Sim-
ilar puriWcation yields for soluble proteins were obtained from the BubR1 constructs 1-310 to 1-318, but increased yields were observed when the
BubR1 constructs 1-322 to 1-328 were used, as compared to the BubR1 construct 1-320. S and E represent induced cell supernatant and eluted frac-
tion at 500 mM imidazole concentrations, respectively.
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shoulder at approximately 220 nm (data is presented
only for construct 1-320) (Fig. 8). The experimental CD
spectrum of construct 1-320 was Wtted using the CON-
TINLL program [37,38] in the the DICROWEB website
[33], to assess the composition of the secondary struc-
ture. The CONTINLL program calculated that the sec-
ondary structural composition of construct 1-320 was
composed of 46.7% -helix, 1.9% -sheet, 10.8% turns,
and 40.6% random coil, whereas the GOR program for
secondary structure prediction predicted that it con-
sisted of 47.8% -helix, 7.8% -sheet, and 44.4% random
coil (Fig. 2). Interestingly, the values for the -helix and
those for the random coil were predicted fairly accu-
rately by both the CONTINLL and the GOR programs,
whereas these programs did not do such a good job inpredicting the values associated with the -sheet. In ret-
rospect, it turned out to be quite appropriate that our
construct design had been predicated on the secondary
structure prediction programs (Fig. 2), considering that
the secondary structure prediction programs accurately
matched the results of the CD experiments done in this
study.
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